Sequenom, Inc. (NASDAQ: SQNM) announced positive results from screening studies using its noninvasive circulating cell-free fetal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE